Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • govt of india

    Tag: govt of india

    You Searched For "govt of india"
    Chemists and Druggists or Pharmacy? DTAB decides on nomenclature

    Chemists and Druggists or Pharmacy? DTAB decides on nomenclature

    Meghna A Singhania20 April 2019 11:44 AM IST
    New Delhi: The highest statutory decision-making body under CDSCO, Drug Technical Advisory Board (DTAB) has given its in principal nod to replace the...
    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Garima18 April 2019 10:15 AM IST
    If the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), under the Ministry of AYUSH goes through the proceeds, would add to...
    Syngene collaborates with BIRAC to set up Centre for Advanced Protein Studies

    Syngene collaborates with BIRAC to set up Centre for Advanced Protein Studies

    Garima7 April 2019 9:30 AM IST
    Bengaluru: Syngene International Ltd., a contract research organization, announced the opening of its Centre for Advanced Protein Studies (CAPS) by...
    NPPA caps trade margins to 30 percent for 42 cancer drugs

    NPPA caps trade margins to 30 percent for 42 cancer drugs

    Meghna A Singhania28 Feb 2019 9:20 AM IST
    As per data available with NPPA, the MRP for 105 brands will be reduced up to 85 per cent entailing minimum saving of Rs 105 crore to consumers, it...
    Digital health services are transforming health sector in India: Nadda

    Digital health services are transforming health sector in India: Nadda

    Meghna A Singhania27 Feb 2019 9:00 AM IST
    The Global Digital Health Partnership facilitates global collaboration and co-operation in the implementation of digital health services.New Delhi:...
    NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report

    NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report

    Meghna A Singhania21 Feb 2019 3:13 PM IST
    However, the move is likely to stimulate retailers to spend more as trade margins on drugs that have somehow bypassed the list and the retailers may...
    NPPA fixes retail price of Emcure pharma

    NPPA fixes retail price of Emcure pharma's HIV drug

    Meghna A Singhania17 Feb 2019 9:30 AM IST
    New Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Emcure...
    Unethical practices by companies in medical devices industry: Nadda apprises Rajya Sabha

    Unethical practices by companies in medical devices industry: Nadda apprises Rajya Sabha

    Meghna A Singhania6 Feb 2019 3:38 PM IST
    New Delhi: Shri JP Nadda, The Union Minister of Health and Family Welfare recently answered many grave questions raised in the Rajya Sabha pointedly...
    SUGAM registration Mandatory: CDSCO directs State drugs controllers to enforce rule

    SUGAM registration Mandatory: CDSCO directs State drugs controllers to enforce rule

    Meghna A Singhania31 Jan 2019 12:46 PM IST
    New Delhi: Through a recent notice, Central Drugs Standard Control Organization informed all drug controllers about online SUGAM registration...
    HC Relief to Reckitt Benckiser in advertisement of ASU drugs case

    HC Relief to Reckitt Benckiser in advertisement of ASU drugs case

    Farhat Nasim17 Jan 2019 5:36 PM IST
    New Delhi: Reckitt Benckiser, over a decade long market player in the health, hygiene and home consumer goods has been smoothly commercialising its...
    Import of drugs in India: Center adds two more ports, Releases Gazette Notification

    Import of drugs in India: Center adds two more ports, Releases Gazette Notification

    Farhat Nasim13 Jan 2019 9:33 AM IST
    New Delhi: An upsurge in the import of drugs is likely to be seen as the government has recently informed about the addition of two new ports for this...
    Relief to Foreign Drugmakers: No price cap on innovative drugs for first five years

    Relief to Foreign Drugmakers: No price cap on innovative drugs for first five years

    Farhat Nasim5 Jan 2019 10:44 AM IST
    New Delhi: Through a recent Gazette notice the Central Government has made amendments to the Drugs Prices Control Orders (DPCO),2013 which aim to...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok